BioSpace News Archive

Fecal microbiota transplantation refers to the practice of transplanting stool from a healthy donor into the gastrointestinal tract of the patient.

Flow diversion devices used in unruptured intracranial aneurysm are endovascular devices that are placed in the parent artery rather than the aneurysm sac through a minimally invasive procedure.

Genomics refers to the study of structure, function and inheritance of the genome of an organism. Genomic technology offer opportunities to improve healthcare across the breadth of medical specialities.

Innate Pharma SA, announced that the Company will hold a conference call on Thursday, March 18, 2021 at 2 p.m. CET / 9 a.m. ET, following the release of its financial results for the full year ending December 31, 2020.

The increasing preference towards hybrid modalities from standalone ones, coupled with the rising popularity of personalized medicines are considered the primary factors propelling the growth of the global nuclear imaging equipment market during the forecast period, 2020 – 2030.

Cold Storage and Distribution Expansions Support Vaccine and Biologics Supply Chain, Keep Pace With Global Industry Trends

111, Inc., a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, announced it has opened two new state-of-the-art, technology-driven fulfillment centers in the Northern cities of Xi’an and Shenyang.

Alchemab using unique approach to explore adaptive immunity - identifying naturally protective antibodies in ‘resilient patients’ to specific diseases

New Data Published in Scientific Reports Reveals Possible Biological Underpinnings of Cancer Patients Hyper-Immune Response to COVID-19 Infection

Anavex Life Sciences Corp. reported that ANAVEX®2-73 is featured in a recent peer-reviewed publication in the journal of Neuropharmacology, titled “Future avenues for Alzheimer’s disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery” from the series of the special issue on ’The Quest for Disease-Modifying Therapies for Neurodegenerative Disorders’.